Genetics, Diagnostics, and Mimics of NEDAMSS

The path to a NEDAMSS diagnosis often begins with a search for answers when a child misses milestones or begins to lose skills. Because this condition is so rare and its symptoms overlap with other disorders, doctors rely on advanced genetic testing alongside clinical evaluations to provide a definitive answer. Understanding how the IRF2BPL gene works and how it is tested can help you navigate the diagnostic process.

The Biology: What the IRF2BPL Gene Does

The IRF2BPL gene acts like a master switch or “transcriptional regulator” in the brain ^[1]. It provides the instructions for a protein that controls when other genes are turned on or off ^[2].

In a healthy brain, this protein lives mostly in the nucleus (the control center of the cell) ^[1]. In children with NEDAMSS, genetic changes cause the protein to behave abnormally:

• Misfolding and Clumping: The altered protein often clumps together in the cytoplasm (the outer part of the cell) instead of staying in the nucleus ^[1].
• Sequestration: These clumps can “trap” the healthy versions of the protein, preventing them from doing their job ^[1].
• Wnt Signaling: This disruption often leads to the overactivation of a biological pathway called Wnt signaling, which is essential for proper brain development but can cause problems when it is out of balance ^[3].

Genotype and Phenotype: A Word of Caution

Doctors look at the type of genetic change (variant) to help understand the condition. However, it is critical to know that variant class or location cannot reliably predict an individual child’s specific course, and this data is based on small cohort studies:

• Truncating/Nonsense Variants: These are like a “stop” sign in the genetic code that causes the protein to be cut short. In some reports, these variants are associated with the most severe forms of the disorder, including early-onset regression, loss of speech, and seizures ^[4][2].
• Missense Variants: These are like a single “typo” in the code where one building block of the protein is swapped for another. While some missense variants cause severe disease, others have been linked to a slightly milder or later-onset course ^[4].
• Location Matters: Where the change occurs in the gene (e.g., near the “RING-finger” domain) can also influence whether symptoms start in infancy or later in childhood ^[5][6].

The Diagnostic Process

A molecular diagnosis of NEDAMSS requires evaluating the clinical context alongside finding a pathogenic or likely pathogenic IRF2BPL variant.

• Testing Methods: This is commonly achieved through a multigene panel, Whole Exome Sequencing (WES), or Whole Genome Sequencing (WGS), which are usually performed using a blood or saliva sample ^[7].
• Trio Testing: This is the most effective way to test. It involves sequencing the DNA of the child and both biological parents at the same time. This helps doctors see if the variant is de novo (a new change in the child) or inherited ^[8].
• VUS and Reanalysis: A Variant of Uncertain Significance (VUS) means the lab found a change but does not have enough evidence to prove it causes disease; a VUS does not confirm a NEDAMSS diagnosis. If your child had genetic testing years ago that came back negative, a reanalysis of that data might find NEDAMSS now that the gene has been more clearly identified in medical research ^[9]. A negative test does not completely exclude a genetic cause.

Evaluating “The Mimics”

Before a genetic diagnosis, many children are initially suspected of having more common conditions. Genetic testing confirms IRF2BPL-related disease, but doctors also use clinical assessment, family history, metabolic evaluations, and ophthalmologic exams to evaluate alternatives:

• Rett Syndrome: Like NEDAMSS, Rett involves regression and loss of speech, but it is typically caused by the MECP2 gene ^[10].
• Batten Disease (NCL): This also causes regression and seizures, but it often involves vision loss, which is not a core feature of NEDAMSS ^[11].
• DRPLA: A rare disorder that causes similar movement issues and seizures. One case of NEDAMSS was only discovered after testing for DRPLA came back negative ^[9].
• Cerebral Palsy: Because NEDAMSS involves movement and muscle tone issues, it is sometimes misdiagnosed as Cerebral Palsy before the progressive nature of the condition becomes clear ^[9].

It is important to note that MRI (brain imaging) and EEG (brain wave) findings in NEDAMSS are often variable or “non-specific.” Normal or non-specific MRI and EEG findings do not exclude NEDAMSS ^[12][9].